ITPR2 (do inglês, inositol 1,4,5-triphosphate receptor, type 2) é uma proteína que é codificado pelo gene humano ITPR2. A proteína codificada por este gene é um receptor para o inositol trifosfato e um canal de cálcio.
JardÃn I, López JJ, Salido GM, Rosado JA (2008). «Functional relevance of the de novo coupling between hTRPC1 and type II IP3 receptor in store-operated Ca2+ entry in human platelets.». Cell. Signal. 20 (4): 737–47. PMID18249094. doi:10.1016/j.cellsig.2007.12.010soft hyphen character character in |autor= at position 6 (ajuda) !CS1 manut: Nomes múltiplos: lista de autores (link)
van Es MA, Van Vught PW, Blauw HM; et al. (2007). «ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.». Lancet neurology. 6 (10): 869–77. PMID17827064. doi:10.1016/S1474-4422(07)70222-3 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Miyachi K, Iwai M, Asada K; et al. (2007). «Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.». Mod Rheumatol. 17 (2): 137–43. PMID17437169. doi:10.1007/s10165-006-0555-6 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Mery L, Magnino F, Schmidt K; et al. (2001). «Alternative splice variants of hTrp4 differentially interact with the C-terminal portion of the inositol 1,4,5-trisphosphate receptors.». FEBS Lett. 487 (3): 377–83. PMID11163362. doi:10.1016/S0014-5793(00)02362-0 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Diaz F, Bourguignon LY (2000). «Selective down-regulation of IP(3)receptor subtypes by caspases and calpain during TNF alpha -induced apoptosis of human T-lymphoma cells.». Cell Calcium. 27 (6): 315–28. PMID11013462. doi:10.1054/ceca.2000.0126
Mayne M, Holden CP, Nath A, Geiger JD (2000). «Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages.». J. Immunol. 164 (12): 6538–42. PMID10843712 !CS1 manut: Nomes múltiplos: lista de autores (link)
Tanimura A, Tojyo Y, Turner RJ (2000). «Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins.». J. Biol. Chem. 275 (35): 27488–93. PMID10874040. doi:10.1074/jbc.M004495200 !CS1 manut: Nomes múltiplos: lista de autores (link)
Jurkovicova D, Sedlakova B, Lacinova L; et al. (2008). «Hypoxia differently modulates gene expression of inositol 1,4,5-trisphosphate receptors in mouse kidney and HEK 293 cell line.». Ann. N. Y. Acad. Sci. 1148: 421–7. PMID19120137. doi:10.1196/annals.1410.034 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Bruce JI, Shuttleworth TJ, Giovannucci DR, Yule DI (2002). «Phosphorylation of inositol 1,4,5-trisphosphate receptors in parotid acinar cells. A mechanism for the synergistic effects of cAMP on Ca2+ signaling.». J. Biol. Chem. 277 (2): 1340–8. PMID11694504. doi:10.1074/jbc.M106609200 !CS1 manut: Nomes múltiplos: lista de autores (link)
Johnson JM, Castle J, Garrett-Engele P; et al. (2003). «Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.». Science. 302 (5653): 2141–4. PMID14684825. doi:10.1126/science.1090100 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)